Antiproliferative effects of SOM230 in EPN prostate cell line

被引:0
|
作者
Rossi, V
Pasquali, D
Gazzerro, G
Abbondanza, C
Bellastella, A
Puca, GA
Sinisi, AA
机构
[1] Univ Naples 2, Dip Internist Clin & Sperimentale, Naples, Italy
[2] Univ Naples 2, Dip Patol Gen, Naples, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The superior therapeutic potential of SOM230 originates from unique structural elements
    Lewis, I
    Bauer, W
    Albert, R
    Chandramouli, N
    Pless, J
    Weckbecker, G
    Bruns, C
    BIOPOLYMERS, 2003, 71 (03) : 366 - 366
  • [22] The superior therapeutic properties of SOM230 originate from unique structural elements
    Lewis, I
    Albert, R
    Bauer, W
    Chandramouli, N
    Pless, J
    Oberer, L
    Bovermann, G
    van der Hoek, J
    Boerlin, V
    Lamberts, SWJ
    Schmid, HA
    Weckbecker, G
    Bruns, C
    CHIMIA, 2004, 58 (04) : 222 - 227
  • [23] The superior therapeutic potential of SOM230 originates from unique structural elements
    Lewis, Ian
    Bauer, Wilfried
    Albert, Rainer
    Chandramouli, Nagarajan
    Pless, Janos
    Weckbecker, Gisbert
    Bruns, Christian
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 721 - 722
  • [24] SOM230 in Cushing's disease complicated by poorly controlled diabetes mellitus
    Fiorentino, C.
    Motta, C.
    Wolosinska, D. T.
    Monti, S.
    Mori, F.
    Toscano, V.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (09) : 731 - 732
  • [25] Phase II trial of SOM230 in patients with unresectable hepatocellular carcinoma (HCC).
    Feun, Lynn G.
    Savaraj, Niramol
    Wangpaichitr, Medhi
    Richman, Stephen P.
    Kwon, Deukwoo
    Dinh, Vy
    Martin, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Stimulatory effect of SOM230 on human and rat adrenal corticosteroid secretion in vitro
    Giraldi, F. Pecori
    Pagliardini, L.
    Cassarino, M. F.
    Martucci, F.
    Sesta, A.
    Castelli, L.
    Montanari, E.
    Schmid, H. A.
    Cavagnini, F.
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2012, 178 (02) : 436 - 439
  • [27] SOM230 in Cushing’s disease complicated by poorly controlled diabetes mellitus
    C. Fiorentino
    C. Motta
    D. T. Wolosinska
    S. Monti
    F. Mori
    V. Toscano
    Journal of Endocrinological Investigation, 2011, 34 : 731 - 732
  • [28] Pasireotide (SOM230) as a Potential Treatment for Endocrine and Non-Endocrine Tumors
    Schmid, Herbert A.
    CURRENT DRUG THERAPY, 2010, 5 (04) : 301 - 311
  • [29] Regulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats
    Silva, AP
    Schoeffter, P
    Weckbecker, G
    Bruns, C
    Schmid, HA
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (03) : R7 - R10
  • [30] Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies
    Kokona, D.
    Mastrodimou, N.
    Pediaditakis, I.
    Charalampopoulos, I.
    Schmid, H. A.
    Thermos, K.
    EXPERIMENTAL EYE RESEARCH, 2012, 103 : 90 - 98